Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Savannah, GA
NPI: 1326052085Primary Practice Location
EFFINGHAM HEALTH SYSTEM
459 Ga Highway 119 S, Springfield, GA
Primary Employer
Candler Medical Oncology Practice, LLC
summitcancercare.com
HQ Phone
Get M.D. Mark's Phone Numberphone_androidMobile
Get M.D. Mark's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardSC State Medical License
GA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 481 | 920 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 286 | 838 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 77 | 128 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 58 | 58 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 38 | 62 |
A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer.
Authors: Thomas Stinchcombe, Harry Harper, Jeffrey Crane, Sridhar Pal, Thomas Hensing, Edwin Mcelroy, Garry Schwartz, Mark Socinski, Daniel Bradford, Carrie Lee
Publication Date: 2011-07-01
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134.
Authors: Anthony Jaslowski, Jeffrey Sosman, Walter Urba, Ian Okazaki, Charles Bane, Brendan Curti, Joanna Brell, Sunandana Chandra, Mark O'Rourke, Bartosz Chmielowski, Noel Laudi, Antoni Ribas, Jedd Wolchok, Robert Conry, Diwakar Davar, Kari Kendra, Sowjanya Reganti, Theodore Logan
Publication Date: 2022-09-27
Desmoplastic Spitz Nevus Combined With Cutaneous Leiomyoma: A Rare Collision Tumor.
Authors: Ieremia, Eleni, Taylor, Mark, Calonje, Eduardo
Journal: Am J Dermatopathol
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, OTHER: Questionnaire Administration, OTHER: Quality-of-Life Assessment, DRUG: Pembrolizumab, DRUG: Pemetrexed, OTHER: Comprehensive Geriatric Assessment
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Docetaxel, BIOLOGICAL: Nivolumab, PROCEDURE: Biospecimen Collection, DRUG: Gemcitabine Hydrochloride, DRUG: Paclitaxel, BIOLOGICAL: Ramucirumab, PROCEDURE: Computed Tomography, DRUG: Cabozantinib S-malate, DRUG: Nab-paclitaxel, PROCEDURE: Echocardiography Test
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: DRUG: Carboplatin, OTHER: Questionnaire Administration, PROCEDURE: Biospecimen Collection, DRUG: Cisplatin, OTHER: Quality-of-Life Assessment, DRUG: Atezolizumab, RADIATION: Intensity-Modulated Radiation Therapy, DRUG: Etoposide, RADIATION: 3-Dimensional Conformal Radiation Therapy
